iRadimed
IRMD
68 hedge funds and large institutions have $83.5M invested in iRadimed in 2018 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 20 increasing their positions, 17 reducing their positions, and 8 closing their positions.
213% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 8
90% more capital invested
Capital invested by funds: $44M → $83.5M (+$39.4M)
33% more funds holding
Funds holding: 51 → 68 (+17)
18% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 17
1.14% more ownership
Funds ownership: 19.91% → 21.05% (+1.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$2.73M |
| 2 |
NA
Navellier & Associates
Reno,
Nevada
|
+$2.53M |
| 3 |
Renaissance Technologies
New York
|
+$2.2M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$1.89M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$1.42M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$5.99M |
| 2 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
-$1.92M |
| 3 |
MIP
Mondrian Investment Partners
London,
United Kingdom
|
-$1.42M |
| 4 |
Boston Partners
Boston,
Massachusetts
|
-$1.3M |
| 5 |
MC
Menta Capital
San Francisco,
California
|
-$1.11M |
IRMD Hedge Fund Activity: Q3 2018 in Review
68 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q3 2018, worth a combined $83.5M — up 90% from $44M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new IRMD positions and 8 closed out — a net gain of 17 holders — while 20 added to existing stakes and 17 trimmed.
The largest buyer was BlackRock, adding an estimated $2.73M. The largest seller was Ameriprise, exiting entirely with an estimated $5.99M sold.
- 68 institutional investors held iRadimed (IRMD) as of Q3 2018, up from 51 in Q2 2018.
- Funds reported $83.5M of iRadimed stock for Q3 2018, up 90% quarter-over-quarter.
- 25 funds opened new iRadimed positions in Q3 2018 and 8 closed out, a net change of +17 holders.
- The largest iRadimed buyer in Q3 2018 was BlackRock, an estimated $2.73M added.
- The largest iRadimed seller in Q3 2018 was Ameriprise, an estimated $5.99M sold.
Based on aggregated 13F filings for Q3 2018.